<DOC>
	<DOC>NCT00567983</DOC>
	<brief_summary>The purpose of this study is to evaluate the effect Restasis has in regards to disease progression.</brief_summary>
	<brief_title>Topical Cyclosporine and Disease Progression</brief_title>
	<detailed_description />
	<mesh_term>Disease Progression</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Mild to Moderate dry eye symptoms Current use of Restasis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
</DOC>